Form 4: RxSight Director Sells Shares Under 10b5-1 Trading Plan

A director of RxSight, Inc. sold 3,519 shares of common stock at an average price of $30.8662 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Shweta Maniar, a director at RxSight, Inc., sold 3,519 shares of common stock on January 22, 2025.
• The shares were sold at a weighted average price of $30.8662.
• The sales were executed under a Rule 10b5-1 trading plan established on August 22, 2024.
• The price range for the sales was between $30.5166 and $31.26 per share.
• Following the transaction, the director still beneficially owns 7,383 shares.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to a pre-planned stock sale by a director. It does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US.
• The use of a 10b5-1 trading plan is a common method for insiders to sell shares while avoiding accusations of trading on non-public information.
• The volume of shares sold is relatively small compared to the overall market capitalization of RxSight, Inc.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the stock price due to the pre-planned nature of the transaction.

Key Dates

Keywords

Form 4, insider trading, Rule 10b5-1, stock sale, RxSight, RXST, director, equity securities